Nectar Lifesciences extends menthol business asset sale deadline

Nectar Lifesciences Limited has extended the completion date for the sale of its menthol business assets. The company and Ceph Lifesciences Private Limited, the purchaser, have mutually agreed to extend the expected completion date to on or before October 20, 2025.

This update follows previous disclosures regarding the asset sale, which involves the transfer and delivery of assets related to Nectar Lifesciences' menthol business.

The announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The company's secretary & compliance officer, Sanjaymohan Singh Rawat, signed the official communication.